Evaluating whether Elite Pharmaceuticals (OTC: ELTP) is a good stock to buy involves analyzing its micro-cap valuation, generic and proprietary drug pipeline progress, and OTC trading liquidity. While speculative investors are often drawn to its low share price and potential product commercialization milestones, micro-cap equities carry elevated financial volatility, lower trading liquidity, and unique market risks that mandate careful risk assessment before purchasing.